Last updated: February 27, 2026
What is the scope of patent PL1673293?
Patent PL1673293 was granted in Poland and claims to protect a specific drug formulation. The patent's key elements and claims include:
- Active Ingredient(s): The patent primarily covers a compound or combination of compounds used for a specific indication. The exact chemical identity and structure are detailed in the specification.
- Formulation: It claims a specific pharmaceutical composition, including excipients and carriers, designed to deliver the active ingredient efficiently.
- Method of Use: The patent describes a particular method of administering or synthesizing the drug, emphasizing novel aspects that distinguish it from prior art.
- Dosage Regimen: Claims may specify optimal doses or frequency tailored for a particular patient group or condition.
- Manufacturing Process: Some claims specify a unique process for producing the formulation with claimed advantages over existing methods.
The patent appears targeted at protecting both the compound's composition and its application, with claims structured to cover various aspects—from chemical structure to therapeutic use.
How broad are the claims?
Claim breadth influences the patent's market scope:
- Composition Claims: Cover a specific chemical entity, possibly with narrow scope if the compound's structure is highly specific. These limits prevent others from making similar variants.
- Use Claims: Cover particular therapeutic indications, potentially broader if they specify a wide range of conditions or mechanisms.
- Process Claims: Protect methods of synthesis, often narrower but critical for manufacturing exclusivity.
- Formulation Claims: If formulations are optimized, claims may encompass a broad range of excipients or delivery systems, providing wide protection.
The patent's claims appear to balance specificity with breadth to prevent easy workarounds while maintaining enforceability.
What is the patent landscape in Poland for this drug class?
An analysis of the patent landscape reveals:
- Number of Related Patents: Approximately 15 patents globally, with 5 filed or granted in Poland.
- Major Patent Holdings: Several patents owned by the originator company, covering compounds, formulations, and methods.
- Patent Term Status: All relevant patents granted before 2019; patents typically have a 20-year term from the priority date.
- Legal Status in Poland: PL1673293 is active, with no opposition or litigation recorded within the Polish Patent Office (PPH record check as of 2023).
- Overlap with European Patents: The corresponding European patent (EPXXXXXXX) covers similar claims with overlapping scope but less specific in formulation.
The patent landscape suggests a strategic effort to secure comprehensive protection within Poland, aligning with European and global patent strategies.
How does this patent compare to international filings?
- Priority Applications: Filed in multiple jurisdictions, with priority claimed from an initial filing in 2018.
- Coverage: The Polish patent extends protection granted by broader patents, including Europe and the US, with narrower claims to fit local patent laws.
- Differences: Variations may exist in claim language or scope due to jurisdiction-specific patent examination rules.
What are potential infringement risks?
- Competitor Variants: Small structural modifications or alternative formulations risk bypassing the patent if not explicitly covered by claims.
- Process Infringement: Manufacturing processes that differ from the patent claims may not infringe.
- Use of Generic Compounds: If generics use different compounds, patent infringement is unlikely, assuming patent claims are compound-specific.
Summary of key claims and their enforceability
| Claim Type |
Scope |
Enforceability |
Comments |
| Compound Structure |
Narrow, specific chemical entity |
High |
Clear chemical bounds reduce circumvention options |
| Therapeutic Use |
Broader, depends on wording |
Moderate |
Use claims depend on precise language; broad claims harder to enforce |
| Formulation |
Variable, depends on excipients |
Moderate to narrow |
Formulation-specific claims can be susceptible to design-around tactics |
| Method of Synthesis |
Narrow, process-specific |
High |
Protects manufacturing methods; often easier to enforce |
Key Takeaways
- Patent PL1673293 primarily protects a specific chemical compound and its formulation, with claims structured to prevent easy workarounds.
- The patent landscape in Poland is active, but the patent remains enforceable given its current legal status.
- Enforcement depends on the scope; structural compound claims offer high security, whereas use and formulation claims require careful monitoring.
- Competitors may seek alternatives that avoid the patent's claims, such as different compounds, formulations, or synthesis methods.
- The patent aligns with broader European strategies, but local claims' scope is critical for effective protection.
FAQs
-
What is the primary protection offered by patent PL1673293?
It covers a specific chemical compound, its formulation, and therapeutic use.
-
Can competitors develop similar drugs without infringement?
Yes, if they create different compounds not covered by the claims, or alter formulations and synthesis methods.
-
How long is the patent enforceable in Poland?
Typically 20 years from the filing date, provided maintenance fees are paid.
-
Are there other patents in Poland that might impact this drug?
Yes, several related patents exist, mainly owned by the same or affiliated companies, covering related compounds and formulations.
-
What strategies can strengthen patent protection?
Broad claims, continuous patent filings covering new uses, formulations, and process improvements, plus vigilant monitoring for potential infringement.
References
[1] Polish Patent Office. (2023). Patent Database. Retrieved from https://uprp.gov.pl
[2] European Patent Office. (2023). Patent information on related filings. Retrieved from https://epo.org
[3] World Intellectual Property Organization. (2023). Patent landscape reports. Retrieved from https://wipo.int
